Work

CREBBP Mutation as a Culprit for Negative SSTR2 PET in Neuroendocrine Tumors

Year: 2025

Type: article

Study design: Observational Study

Source: Molecular Imaging and Biology

DOI: 10.1007/s11307-025-02040-1

Authors: Arvin Haj-Mirzaian, Shadi A. Esfahani, Umar Mahmood, Pedram Heidari

Institutions: Harvard University, Massachusetts General Hospital

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Massachusetts General Hospital, National Institutes of Health, National Cancer Institute

Awards: Enhancing the therapeutic effect of receptor radionuclide therapy in neuroendocrine tumors by somatostatin receptor upregulation, G9000316912, Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma

OpenAlex ID: W4413051449

FWCI:

Cites: 32

Cited by:

Related to: 10